Clinical Trial

A Novel Psychological Intervention for Adults With Bipolar Disorder and Attention Deficit Hyperactivity Disorder Comorbidity (VECTOR)

Study acronym: VECTOR
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 26, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Cognitive dysfunctions are present in Bipolar Disorder (BD) and Attention Deficit Hyperactivity Disorder (ADHD) and may negatively impact psychosocial functioning. Further, comorbid BD and ADHD (BD-ADHD) is prevalent, associated with an earlier BD onset and a less favorable prognosis. Nevertheless, there is a paucity of research dedicated to the characterization and treatment of comorbid BD-ADHD. This study aims to develop and evaluate the effectiveness of a novel psychological group intervention (VECTOR) for adults with BD-ADHD. VECTOR integrates elements from Cognitive Behavioral Therapy (CBT) for ADHD and Functional Remediation (FR) for BD. Eighty patients will be randomized (1:1) to receive either the VECTOR program (12 weekly group sessions) or treatment as usual (TAU). It is expected that the VECTOR program will result in greater improvements in functioning and symptom reduction compared to TAU.
Trial Details
NCT Number NCT07039903
Lead Sponsor Hospital Universitari Vall d'Hebron Research Institute
Collaborators: Hospital Clinic of Barcelona
Conditions ADHD, BD
Enrollment 68 participants
Start Date 2025-09-01
Primary Completion 2026-07-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-26